ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Aerovate Therapeutics Inc

Aerovate Therapeutics Inc (AVTE)

2.53
-0.02
(-0.78%)
Closed December 21 4:00PM
2.5305
0.0005
(0.02%)
After Hours: 6:01PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.53
Bid
2.46
Ask
2.66
Volume
768,554
2.45 Day's Range 2.64
1.25 52 Week Range 32.415
Market Cap
Previous Close
2.55
Open
2.53
Last Trade
5
@
2.48
Last Trade Time
Financial Volume
$ 1,949,248
VWAP
2.5363
Average Volume (3m)
774,424
Shares Outstanding
28,874,513
Dividend Yield
-
PE Ratio
-0.97
Earnings Per Share (EPS)
-2.62
Revenue
-
Net Profit
-75.52M

About Aerovate Therapeutics Inc

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was $2.55. Over the last year, Aerovate Therapeutics shares have traded in a share price range of $ 1.25 to $ 32.415.

Aerovate Therapeutics currently has 28,874,513 shares outstanding. The market capitalization of Aerovate Therapeutics is $73.63 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -0.97.

AVTE Latest News

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm PR Newswire NEW YORK, Nov. 1, 2024 NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.025-0.9784735812132.5552.63342.51606022.54543536CS
4-0.07-2.692307692312.62.7252.51641132.60714139CS
120.4622.22222222222.0731.957744242.47773563CS
261.1786.02941176471.3631.257021352.08808258CS
52-16.82-86.925064599519.3532.4151.255521334.73578069CS
156-6.77-72.79569892479.332.4151.252420937.89018818CS
260-25.47-90.96428571432832.4151.252266958.58235801CS

AVTE - Frequently Asked Questions (FAQ)

What is the current Aerovate Therapeutics share price?
The current share price of Aerovate Therapeutics is $ 2.53
How many Aerovate Therapeutics shares are in issue?
Aerovate Therapeutics has 28,874,513 shares in issue
What is the market cap of Aerovate Therapeutics?
The market capitalisation of Aerovate Therapeutics is USD 73.63M
What is the 1 year trading range for Aerovate Therapeutics share price?
Aerovate Therapeutics has traded in the range of $ 1.25 to $ 32.415 during the past year
What is the PE ratio of Aerovate Therapeutics?
The price to earnings ratio of Aerovate Therapeutics is -0.97
What is the reporting currency for Aerovate Therapeutics?
Aerovate Therapeutics reports financial results in USD
What is the latest annual profit for Aerovate Therapeutics?
The latest annual profit of Aerovate Therapeutics is USD -75.52M
What is the registered address of Aerovate Therapeutics?
The registered address for Aerovate Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Aerovate Therapeutics website address?
The website address for Aerovate Therapeutics is www.aerovatetx.com
Which industry sector does Aerovate Therapeutics operate in?
Aerovate Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
$ 80.55
(8.54%)
281.23M

Your Recent History